GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

10812	Companies
234240	Keywords
163037	Articles
125255	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 02/10/2025 at 07:30, 1 year 5 months ago

GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders
GENFIT announces final terms for dual proposal to the 2025 OCEANEs holders, offering to repurchase bonds at EUR 32.00 or pay a consent fee of EUR 0.60 per bond. Proposals subject to bondholders' approval and closing of royalty financing

Repurchase Royalty Financing GENFIT Consent Fee 2025 OCEANEs
PRESS RELEASE

published on 02/10/2025 at 07:30, 1 year 5 months ago

GENFIT annonce les termes définitifs de sa double proposition aux porteurs d’OCEANEs 2025
GENFIT annonce les termes de sa double proposition aux porteurs d'OCEANEs 2025, incluant le rachat des obligations ou un paiement financier, liés au royalty financing avec HCRx. Modalités d'approbation et mise en œuvre

Rachat Royalty Financing GENFIT OCEANEs 2025 Contrepartie Financière
BRIEF

published on 02/06/2025 at 22:15, 1 year 6 months ago

GENFIT dévoile ses futurs essais cliniques et attentes pour 2025

Biopharmaceutique Essais Cliniques 2025 GENFIT ACLF
BRIEF

published on 02/06/2025 at 22:15, 1 year 6 months ago

GENFIT unveils its future clinical trials and expectations for 2025

Clinical Trials Biopharmaceutical 2025 GENFIT ACLF
PRESS RELEASE

published on 02/06/2025 at 22:10, 1 year 6 months ago

GENFIT présente le design de ses prochains essais cliniques et rappelle les grandes étapes de développement et données cliniques attendues en 2025
GENFIT présente le design de ses prochains essais cliniques pour son portefeuille ACLF et rappelle les données cliniques attendues en 2025. Le Directeur Général annonce quatre séries de données cliniques attendues d'ici fin 2025

Développement Essais Cliniques GENFIT ACLF Données Cliniques
PRESS RELEASE

published on 02/06/2025 at 22:10, 1 year 6 months ago

GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025
GENFIT outlines anticipated new clinical trial initiations, development milestones, and data readouts in 2025, focusing on Acute on-Chronic Liver Failure (ACLF) pipeline

Clinical Trials Biopharmaceutical 2025 GENFIT ACLF Pipeline
BRIEF

published on 01/30/2025 at 08:45, 1 year 6 months ago

GENFIT Announces €185 Million Royalty Financing Agreement

Biopharmaceutical Royalty Financing GENFIT Debt Resolution ACLF Development
BRIEF

published on 01/30/2025 at 08:45, 1 year 6 months ago

GENFIT annonce un accord de financement de 185 millions d'euros sous forme de redevances

Biopharmaceutique GENFIT Résolution De La Dette Financement Par Redevances Développement De L'ACLF
PRESS RELEASE

published on 01/30/2025 at 08:40, 1 year 6 months ago

GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan
GENFIT announces non-dilutive royalty financing agreement with HealthCare Royalty, resolving debt overhang. Transaction to strengthen ACLF pipeline and extend cash runway into 2027

HealthCare Royalty Royalty Financing GENFIT Debt Overhang ACLF Pipeline
BRIEF

published on 01/13/2025 at 22:15, 1 year 6 months ago

Bilan semestriel du contrat de liquidité de GENFIT avec le CIC

Bilan Semestriel Liquidité Crédit Industriel Et Commercial Titres GENFIT

Accesswire

Published on 08/08/2026 at 00:00, 9 hours 45 minutes ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 10 hours 30 minutes ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 10 hours 45 minutes ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 11 hours 15 minutes ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 11 hours 30 minutes ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/07/2026 at 23:21, 10 hours 24 minutes ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 14 hours 15 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 14 hours 30 minutes ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 15 hours 35 minutes ago

Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 15 hours 45 minutes ago

E-PANGO: Composition du capital au 31 juillet 2026

Les Echos

Published on 08/07/2026 at 18:54, 14 hours 51 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 14 hours 51 minutes ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 15 hours 5 minutes ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 15 hours 5 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 15 hours 45 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE